← Leaderboards
Babu J Padanilam
Icahn School Of Medicine At Mount Sinai
$6,430,951
Attributed
$7,460,326
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–23$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,460,326 · 6
By mechanism
R01$7,310,326 · 5
R56$150,000 · 1
Top collaborators
- David Oupicky5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Octavia Bane$1,531,911
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationPathway InteractionsAcute Renal Failure With Renal Papillary NecrosisCell DeathKidneyInjuryBasePreventChronic Kidney FailureInflammationTissuesReperfusion InjuryReportingOxidative StressCellsInflammatoryKnockout MiceEventOrganAffectApoptoticMediatingSignal PathwaySignal Transduction
Grant awards (22)
Neuromodulation of long-term sequelae of ischemic acute kidney injury$454,321
R01 · FY2023 · DK · contact PI
Neuromodulation of long-term sequelae of ischemic acute kidney injury$454,321
R01 · FY2022 · DK · contact PI
Reno-protective mechanisms of EETs in acute and chronic obstructive nephropathy$430,552
R01 · FY2022 · DK · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2022 · DK
Neuromodulation of long-term sequelae of ischemic acute kidney injury$485,497
R01 · FY2021 · DK · contact PI
Reno-protective mechanisms of EETs in acute and chronic obstructive nephropathy$431,720
R01 · FY2021 · DK · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2021 · DK
Neuromodulation of long-term sequelae of ischemic acute kidney injury$458,806
R01 · FY2020 · DK · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2020 · DK
Reno-protective mechanisms of EETs in acute and chronic obstructive nephropathy$388,421
R01 · FY2020 · DK · contact PI
Reno-protective mechanisms of EETs in acute and chronic obstructive nephropathy$425,469
R01 · FY2019 · DK · contact PI
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2019 · DK
Development of siRNA conjugates for combination treatment of acute kidney injury$411,750
R01 · FY2018 · DK
Regulation of Apoptosis in Renal Ischemia$294,379
R01 · FY2013 · DK · contact PI
Regulation of Apoptosis in Renal Ischemia$305,056
R01 · FY2012 · DK · contact PI
Mechanisms of selective glycolytic inhibition in ischemic kidney proximal tubles$150,000
R56 · FY2012 · DK · contact PI
Regulation of Apoptosis in Renal Ischemia$305,056
R01 · FY2011 · DK · contact PI
Regulation of Apoptosis in Renal Ischemia$371,250
R01 · FY2010 · DK · contact PI
PROTEIN KINASE C IN ISCHEMIC RENAL INJURY AND REPAIR$150,528
R01 · FY2002 · DK
PROTEIN KINASE C IN ISCHEMIC RENAL INJURY AND REPAIR$146,140
R01 · FY2001 · DK
PROTEIN KINASE C IN ISCHEMIC RENAL INJURY AND REPAIR$82,073
R01 · FY2000 · DK
PROTEIN KINASE C IN ISCHEMIC RENAL INJURY AND REPAIR$67,987
R01 · FY2000 · DK